Quarterly report pursuant to Section 13 or 15(d)

OPERATING SEGMENTS - Narrative (Details)

v3.22.2
OPERATING SEGMENTS - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jul. 01, 2022
Jul. 02, 2021
Jul. 01, 2022
Jul. 02, 2021
Segment Reporting Information [Line Items]        
Equity Method Investment, Other than Temporary Impairment $ 96   $ 96  
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees 35 $ 60 30 $ 23
Gain (Loss) on Sale of Previously Unissued Stock by Equity Investee     (24)  
Tax litigation expense   4   13
Productivity and Reinvestment        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives 19 22 29 40
CCA        
Segment Reporting Information [Line Items]        
Gain (Loss) on Disposition of Business   695   695
BodyArmor        
Segment Reporting Information [Line Items]        
Gain (loss) related to BodyArmor transaction (13)   (8)  
Europe, Middle East & Africa        
Segment Reporting Information [Line Items]        
Equity Method Investment, Other than Temporary Impairment 96   96  
Europe, Middle East & Africa | Strategic Realignment        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives   11   61
Latin America Segment | Strategic Realignment        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives       11
North America Segment        
Segment Reporting Information [Line Items]        
Business Exit Costs     23  
North America Segment | Operating Income (Loss)        
Segment Reporting Information [Line Items]        
Business Exit Costs 11 16 22 35
North America Segment | Strategic Realignment        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives   1   13
North America Segment | BodyArmor        
Segment Reporting Information [Line Items]        
Gain (loss) related to BodyArmor transaction 2   21  
Asia Pacific | Strategic Realignment        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives       13
Bottling investments        
Segment Reporting Information [Line Items]        
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees 35 60 30 55
Corporate        
Segment Reporting Information [Line Items]        
Debt and Equity Securities, Gain (Loss) (267) 203 (371) 336
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees       (32)
Gain (Loss) on Sale of Previously Unissued Stock by Equity Investee     (24)  
Tax litigation expense   4   13
Charges related to debt extinguishment   592   650
Corporate | Strategic Realignment        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives   46   107
Corporate | Strategic Realignment | Operating Income (Loss)        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives   17   24
Corporate | Productivity and Reinvestment        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives 19 22 29 40
Corporate | fairlife        
Segment Reporting Information [Line Items]        
Contingent Consideration Liability 917 $ 247 939 $ 251
Corporate | BodyArmor        
Segment Reporting Information [Line Items]        
Gain (loss) related to BodyArmor transaction $ (15)   $ (29)